TP53 and cancer: These variants not only bind wild-type p53 and cause dominant-negative (DN) effects, but may also be converted to oncogenic proteins via GOF, promoting various cellular responses such as carcinogenesis, cancer cell proliferation, invasion, metastasis, tumor microenvironment establishment, genomic instability, and metabolic reprogramming [99,100].